HUE069173T2 - Piridazinil tiazolkarboxamid vegyület - Google Patents
Piridazinil tiazolkarboxamid vegyületInfo
- Publication number
- HUE069173T2 HUE069173T2 HUE20906466A HUE20906466A HUE069173T2 HU E069173 T2 HUE069173 T2 HU E069173T2 HU E20906466 A HUE20906466 A HU E20906466A HU E20906466 A HUE20906466 A HU E20906466A HU E069173 T2 HUE069173 T2 HU E069173T2
- Authority
- HU
- Hungary
- Prior art keywords
- pyridazinyl
- thiazolecarboxamide compound
- thiazolecarboxamide
- compound
- pyridazinyl thiazolecarboxamide
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
- A61K31/50—Pyridazines; Hydrogenated pyridazines
- A61K31/501—Pyridazines; Hydrogenated pyridazines not condensed and containing further heterocyclic rings
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
- A61K31/5375—1,4-Oxazines, e.g. morpholine
- A61K31/5386—1,4-Oxazines, e.g. morpholine spiro-condensed or forming part of bridged ring systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
- C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
- C07D487/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D498/00—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D498/02—Heterocyclic compounds containing in the condensed system at least one hetero ring having nitrogen and oxygen atoms as the only ring hetero atoms in which the condensed system contains two hetero rings
- C07D498/10—Spiro-condensed systems
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2019233673 | 2019-12-25 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE069173T2 true HUE069173T2 (hu) | 2025-02-28 |
Family
ID=76574296
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE20906466A HUE069173T2 (hu) | 2019-12-25 | 2020-12-24 | Piridazinil tiazolkarboxamid vegyület |
Country Status (31)
| Country | Link |
|---|---|
| US (1) | US12227517B2 (hu) |
| EP (1) | EP4083038B1 (hu) |
| JP (1) | JP6948659B1 (hu) |
| KR (1) | KR20220119702A (hu) |
| CN (3) | CN115626919A (hu) |
| AR (1) | AR120896A1 (hu) |
| AU (1) | AU2020413997A1 (hu) |
| BR (1) | BR112022012637A2 (hu) |
| CA (1) | CA3165889A1 (hu) |
| CL (1) | CL2022001752A1 (hu) |
| CO (1) | CO2022009124A2 (hu) |
| CR (1) | CR20220328A (hu) |
| DK (1) | DK4083038T3 (hu) |
| DO (1) | DOP2022000137A (hu) |
| EC (1) | ECSP22057324A (hu) |
| ES (1) | ES2995459T3 (hu) |
| FI (1) | FI4083038T3 (hu) |
| HR (1) | HRP20241588T1 (hu) |
| HU (1) | HUE069173T2 (hu) |
| IL (1) | IL294136A (hu) |
| JO (1) | JOP20220163A1 (hu) |
| LT (1) | LT4083038T (hu) |
| MX (1) | MX2022007993A (hu) |
| PE (1) | PE20230163A1 (hu) |
| PH (1) | PH12022551569A1 (hu) |
| PL (1) | PL4083038T3 (hu) |
| PT (1) | PT4083038T (hu) |
| SA (1) | SA522433129B1 (hu) |
| TW (3) | TW202413376A (hu) |
| WO (1) | WO2021132422A1 (hu) |
| ZA (1) | ZA202207543B (hu) |
Families Citing this family (14)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| PH12022551441A1 (en) | 2019-12-24 | 2023-11-20 | Carna Biosciences Inc | Diacylglycerol kinase modulating compounds |
| AR120896A1 (es) * | 2019-12-25 | 2022-03-30 | Astellas Pharma Inc | COMPUESTO DE PIRIDAZINIL-TIAZOLCARBOXAMIDA COMO INHIBIDORES DE DGKz |
| US20230167078A1 (en) | 2020-04-24 | 2023-06-01 | Bayer Aktiengesellschaft | Substituted aminothiazoles as dgkzeta inhibitors for immune activation |
| WO2022114164A1 (ja) * | 2020-11-30 | 2022-06-02 | アステラス製薬株式会社 | ヘテロアリールカルボキシアミド化合物 |
| CA3222439A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
| CA3222277A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
| JP2024522594A (ja) | 2021-06-23 | 2024-06-21 | ギリアード サイエンシーズ， インコーポレイテッド | ジアシルグリセロールキナーゼ調節化合物 |
| WO2022271677A1 (en) | 2021-06-23 | 2022-12-29 | Gilead Sciences, Inc. | Diacylglyercol kinase modulating compounds |
| CN114621214B (zh) * | 2022-04-25 | 2024-04-26 | 宜春学院 | 一种抗菌席夫碱n-酰化物及其制备方法和应用 |
| US20240217989A1 (en) * | 2022-11-18 | 2024-07-04 | Incyte Corporation | Heteroaryl Fluoroalkenes As DGK Inhibitors |
| WO2024151346A1 (en) * | 2023-01-12 | 2024-07-18 | Incyte Corporation | Heteroaryl fluoroalkenes as dgk inhibitors |
| WO2024165469A1 (en) | 2023-02-06 | 2024-08-15 | Bayer Aktiengesellschaft | Combinations of dgk (diacylglycerol kinase) inhibitors and immune checkpoint inhibitors and modulators |
| WO2024199387A1 (zh) * | 2023-03-30 | 2024-10-03 | 微境生物医药科技(上海)有限公司 | 作为DGKζ抑制剂的化合物 |
| WO2024208198A1 (zh) * | 2023-04-06 | 2024-10-10 | 微境生物医药科技(上海)有限公司 | 作为DGKζ抑制剂的噻唑类化合物 |
Family Cites Families (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US7381401B2 (en) | 2004-01-08 | 2008-06-03 | The University Of Chicago | T cell anergy is reversed by active Ras and regulated by diacylglycerol kinase |
| EP1848435B1 (en) | 2005-01-25 | 2016-01-20 | Synta Pharmaceuticals Corp. | Compounds against inflammations and immune-related uses |
| AU2007208225B2 (en) * | 2006-01-25 | 2013-05-02 | Synta Pharmaceuticals Corp. | Thiazole and thiadiazole compounds for inflammation and immune-related uses |
| US8163746B2 (en) | 2006-04-19 | 2012-04-24 | Astellas Pharma Inc. | Azolecarboxamide derivative |
| AU2007314342B2 (en) * | 2006-10-31 | 2013-02-21 | Merck Sharp & Dohme Corp. | Anilinopiperazine Derivatives and methods of use thereof |
| AU2018328768A1 (en) | 2017-09-06 | 2020-03-12 | Propellon Therapeutics Inc. | Inhibitors of WDR5 protein-protein binding |
| PL3814348T3 (pl) * | 2018-06-27 | 2023-09-11 | Bristol-Myers Squibb Company | Podstawione związki naftyrydynonu przydatne jako aktywatory komórek t |
| AR120896A1 (es) | 2019-12-25 | 2022-03-30 | Astellas Pharma Inc | COMPUESTO DE PIRIDAZINIL-TIAZOLCARBOXAMIDA COMO INHIBIDORES DE DGKz |
| US20230167078A1 (en) | 2020-04-24 | 2023-06-01 | Bayer Aktiengesellschaft | Substituted aminothiazoles as dgkzeta inhibitors for immune activation |
| WO2022114164A1 (ja) * | 2020-11-30 | 2022-06-02 | アステラス製薬株式会社 | ヘテロアリールカルボキシアミド化合物 |
-
2020
- 2020-12-23 AR ARP200103641A patent/AR120896A1/es unknown
- 2020-12-24 TW TW112145680A patent/TW202413376A/zh unknown
- 2020-12-24 CR CR20220328A patent/CR20220328A/es unknown
- 2020-12-24 EP EP20906466.6A patent/EP4083038B1/en active Active
- 2020-12-24 BR BR112022012637A patent/BR112022012637A2/pt unknown
- 2020-12-24 PH PH1/2022/551569A patent/PH12022551569A1/en unknown
- 2020-12-24 DK DK20906466.6T patent/DK4083038T3/da active
- 2020-12-24 LT LTEPPCT/JP2020/048337T patent/LT4083038T/lt unknown
- 2020-12-24 MX MX2022007993A patent/MX2022007993A/es unknown
- 2020-12-24 KR KR1020227025714A patent/KR20220119702A/ko active Pending
- 2020-12-24 PL PL20906466.6T patent/PL4083038T3/pl unknown
- 2020-12-24 HR HRP20241588TT patent/HRP20241588T1/hr unknown
- 2020-12-24 JP JP2021531562A patent/JP6948659B1/ja active Active
- 2020-12-24 WO PCT/JP2020/048337 patent/WO2021132422A1/ja active Application Filing
- 2020-12-24 TW TW112145679A patent/TW202413375A/zh unknown
- 2020-12-24 FI FIEP20906466.6T patent/FI4083038T3/fi active
- 2020-12-24 HU HUE20906466A patent/HUE069173T2/hu unknown
- 2020-12-24 JO JOP/2022/0163A patent/JOP20220163A1/ar unknown
- 2020-12-24 CN CN202211308277.1A patent/CN115626919A/zh active Pending
- 2020-12-24 PE PE2022001161A patent/PE20230163A1/es unknown
- 2020-12-24 ES ES20906466T patent/ES2995459T3/es active Active
- 2020-12-24 US US17/427,426 patent/US12227517B2/en active Active
- 2020-12-24 AU AU2020413997A patent/AU2020413997A1/en active Pending
- 2020-12-24 CN CN202211308268.2A patent/CN115590854B/zh active Active
- 2020-12-24 CA CA3165889A patent/CA3165889A1/en active Pending
- 2020-12-24 TW TW109146029A patent/TW202136275A/zh unknown
- 2020-12-24 CN CN202080011114.XA patent/CN113365994B/zh active Active
- 2020-12-24 PT PT209064666T patent/PT4083038T/pt unknown
- 2020-12-24 IL IL294136A patent/IL294136A/en unknown
-
2022
- 2022-06-23 SA SA522433129A patent/SA522433129B1/ar unknown
- 2022-06-24 CL CL2022001752A patent/CL2022001752A1/es unknown
- 2022-06-24 DO DO2022000137A patent/DOP2022000137A/es unknown
- 2022-06-30 CO CONC2022/0009124A patent/CO2022009124A2/es unknown
- 2022-07-07 ZA ZA2022/07543A patent/ZA202207543B/en unknown
- 2022-07-21 EC ECSENADI202257324A patent/ECSP22057324A/es unknown
Also Published As
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| LT4083038T (lt) | Piridazinilo tiazolkarboksamido junginys | |
| ZA202106194B (en) | Fungicidal compounds | |
| PL3827042T3 (pl) | Związek wielo-azyrydynowy | |
| GB201905721D0 (en) | Compounds | |
| GB202011800D0 (en) | Compound | |
| ZA202101671B (en) | Imidazopyridinone compound | |
| GB201910305D0 (en) | Compounds | |
| GB201916915D0 (en) | Compounds | |
| GB201908536D0 (en) | Compounds | |
| GB201908171D0 (en) | Compounds | |
| GB201910304D0 (en) | Compounds | |
| GB201908095D0 (en) | Carboxy-MIDA-boronate compounds | |
| GB201908466D0 (en) | Compound | |
| GB201918424D0 (en) | Compounds | |
| GB201917895D0 (en) | Compounds | |
| GB201917893D0 (en) | Compounds | |
| GB201917891D0 (en) | Compounds | |
| GB201916847D0 (en) | Compounds | |
| GB201916572D0 (en) | Compounds | |
| GB201916595D0 (en) | Compounds | |
| GB201916597D0 (en) | Compounds | |
| GB201916142D0 (en) | Compounds | |
| GB201914208D0 (en) | Compounds | |
| GB201913633D0 (en) | Compounds | |
| GB201913541D0 (en) | Compounds |